Literature DB >> 26000107

Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis.

Alessia Alunno1, Elena Bartoloni1, Giuseppe Nocentini2, Onelia Bistoni1, Simona Ronchetti2, Maria Grazia Petrillo2, Carlo Riccardi2, Roberto Gerli1.   

Abstract

Regulatory T cells (Treg) are a CD4(+) lymphocyte subset involved in self-tolerance and autoimmunity prevention. There is evidence for a phenotypic and/or functional impairment of this cell subset during the natural history of several chronic autoimmune/inflammatory diseases, including rheumatoid arthritis (RA). Although the intracellular transcription factor FoxP3 is thought to be the master regulator of Treg cell function, a number of other molecules expressed on the cell surface have been proposed for the identification of Treg cells. This is important in order to favour their possible selective isolation and in the development of new therapeutic strategies. In the present paper, available data on phenotypic and functional characterization of Treg cells in both peripheral blood and synovial fluid from RA patients are reviewed and their possible pathogenic role in triggering and perpetuating rheumatoid joint inflammation is discussed.

Entities:  

Keywords:  FoxP3 GITR; Rheumatoid arthritis; Treg cells

Year:  2010        PMID: 26000107      PMCID: PMC4389058          DOI: 10.1007/s13317-010-0008-2

Source DB:  PubMed          Journal:  Auto Immun Highlights        ISSN: 2038-0305


  54 in total

Review 1.  The role of T cells in rheumatoid arthritis: new subsets and new targets.

Authors:  Myew-Ling Toh; Pierre Miossec
Journal:  Curr Opin Rheumatol       Date:  2007-05       Impact factor: 5.006

Review 2.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

3.  Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells.

Authors:  Hyung W Lim; Hal E Broxmeyer; Chang H Kim
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

4.  Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.

Authors:  E Toubi; A Kessel; Z Mahmudov; K Hallas; M Rozenbaum; I Rosner
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

5.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.

Authors:  Duojia Cao; Vivianne Malmström; Clare Baecher-Allan; David Hafler; Lars Klareskog; Christina Trollmo
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 7.  Identification of regulatory T cells in systemic lupus erythematosus.

Authors:  Roberto Gerli; Giuseppe Nocentini; Alessia Alunno; Elena Bartoloni Bocci; Rodolfo Bianchini; Onelia Bistoni; Carlo Riccardi
Journal:  Autoimmun Rev       Date:  2009-02-08       Impact factor: 9.754

8.  CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.

Authors:  Sandra Klein; Cosima C Kretz; Peter H Krammer; Annegret Kuhn
Journal:  J Invest Dermatol       Date:  2009-11-26       Impact factor: 8.551

9.  Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis.

Authors:  Z Jiao; W Wang; R Jia; J Li; H You; L Chen; Y Wang
Journal:  Scand J Rheumatol       Date:  2007 Nov-Dec       Impact factor: 3.641

10.  Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.

Authors:  B Zhang; X Zhang; F L Tang; L P Zhu; Y Liu; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2008-01-16       Impact factor: 19.103

View more
  8 in total

1.  Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Authors:  Leilei Zhou; Tianyi Cao; Yufeng Wang; Hui Yao; Guanhuan Du; Guangjie Chen; Xiaoyin Niu; Guoyao Tang
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

2.  Epstein-barr virus as a trigger of autoimmune liver diseases.

Authors:  Eirini I Rigopoulou; Daniel S Smyk; Claire E Matthews; Charalambos Billinis; Andrew K Burroughs; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Adv Virol       Date:  2012-05-28

Review 3.  Translating Treg Therapy in Humanized Mice.

Authors:  Susanne A Hahn; Iris Bellinghausen; Bettina Trinschek; Christian Becker
Journal:  Front Immunol       Date:  2015-12-14       Impact factor: 7.561

4.  Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis.

Authors:  Daniel Smyk; Eirini I Rigopoulou; Nicola Bizzaro; Dimitrios P Bogdanos
Journal:  Auto Immun Highlights       Date:  2012-01-13

5.  Intra-Articular Injection of Human Synovial Membrane-Derived Mesenchymal Stem Cells in Murine Collagen-Induced Arthritis: Assessment of Immunomodulatory Capacity In Vivo.

Authors:  Minglu Yan; Xin Liu; Qiujie Dang; He Huang; Fan Yang; Yang Li
Journal:  Stem Cells Int       Date:  2017-06-21       Impact factor: 5.443

6.  Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model.

Authors:  Giulia Di Benedetto; Chiara Burgaletto; Anna R Carta; Salvatore Saccone; Laurence Lempereur; Giovanna Mulas; Carla Loreto; Renato Bernardini; Giuseppina Cantarella
Journal:  J Neuroinflammation       Date:  2019-08-13       Impact factor: 8.322

Review 7.  Boosting regulatory T cell function for the treatment of autoimmune diseases - That's only half the battle!

Authors:  Janine Schlöder; Fatemeh Shahneh; Franz-Joseph Schneider; Björn Wieschendorf
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 8.  Synovial membrane mesenchymal stem cells: past life, current situation, and application in bone and joint diseases.

Authors:  Na Li; Jinfang Gao; Liangyu Mi; Gailian Zhang; Liyun Zhang; Na Zhang; Rongxiu Huo; Junping Hu; Ke Xu
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.